Natural health product · DIN 00789429
Pancrease MT 16
No: licence discontinued
The licence holder discontinued the product licence.
Licence status Discontinued; licensed October 5, 2009.
- DIN
- 00789429
- Licence holder
- Janssen Inc.Toronto, Ontario, Canada
- Dosage form
- Capsule
- Route
- Oral
- Licensing route
- Transitional DIN
- First licensed
- October 5, 2009
Medicinal ingredients
Per dosage unit, as licensed.
| Ingredient | Amount | Source and potency |
|---|---|---|
| Pancrelipase | 194.2 mg | Extracted from hog pancreata; 16,000 usp units Lipase |
| Pancrelipase | — | Extracted from hog pancreata; 48,000 usp units Amylase |
| Pancrelipase | — | Extracted from hog pancreata; 48,000 usp units Protease |
What it is licensed for
The licence’s own wording. Directions, doses, cautions and warnings are on the official record and the label.
- For the treatment of steatorrhea secondary to pancreatic insufficiency in disorders such as cystic fibrosis or chronic pancreatitis.
Non-medicinal ingredients
Gelatin; Microcrystalline cellulose; Simethicone emulsion; Wax, Montan glycol; Purified water; Magnesium Stearate; Talc; Eudragit L30 D-55; Crospovidone; Opacode black; Triethyl Citrate; Silica colloidal anhydrous